Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

ENTREMED INC
Mes dernières consult.
Most popular
  Report  
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The firm develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

The company was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA532012Executive Chairman
Cynthia Wong Hu482006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA512011Chief Accounting Officer & Vice President-Finance
Alexander A. Zukiwski, MD602017Chief Medical Officer
Zuie Chin Huang, MBA522013Independent Director
Yue Wu PhD, MBA542013Independent Director
Franklin Cary Salisbury, Jr.622014Independent Director
Rajesh C. Shrotriya, MD742014Independent Director
Quan Zhou, PhD602016Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 86,224,843 42,958,541 49.8% 79,545 0.1% 49.8%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 11,547,675 13.4%
Hexie Aiqi Investment Management Beijing Co., Ltd. 10,198,518 11.8%
IDG Capital Partners Co., Ltd. 8,538,803 9.91%
Hung Ka Kung 7,888,883 9.16%
Emerging Technology Partners LLC 5,399,096 6.27%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 5.73%
The Vanguard Group, Inc. 1,276,133 1.48%
Wei-Wu He PhD, MBA 847,527 0.98%
Wellington Shields Capital Management LLC 790,256 0.92%
Wellington Shields & Co. LLC (Investment Management) 625,118 0.73%
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC502
CELLTRION, INC.--.--%33 593
IQVIA HOLDINGS INC7.88%21 859
LONZA GROUP2.81%19 855
INCYTE CORPORATION-22.94%15 470
ALNYLAM PHARMACEUTICALS, INC.-17.65%10 517
SEATTLE GENETICS, INC.22.95%10 408
NEKTAR THERAPEUTICS-2.60%9 832
EXACT SCIENCES CORPORATION31.96%8 471
QIAGEN NV6.08%8 430
ALKERMES PLC-6.16%7 902
SAGE THERAPEUTICS INC0.15%7 540
ICON PLC21.75%7 306
BIO-TECHNE CORP26.25%6 146
PRA HEALTH SCIENCES INC4.82%6 110
CHARLES RIVER LABORATORIES INTL. INC6.83%5 556
IONIS PHARMACEUTICALS INC-13.66%5 451
FIBROGEN INC34.76%5 162
UNITED THERAPEUTICS CORPORATION-20.59%5 116
FOUNDATION MEDICINE INC100.07%5 065
SYNEOS HEALTH INC12.16%5 000
Connections : EntreMed Inc
Beijing Genetron Biotechnology Co. Ltd.
MithraGen, Inc.
Circle Internet Financial Ltd.
Human Longevity, Inc.
Spectrum Pharmaceuticals Cayman LP
Emerging Technology Partners LLC
Superdata Software Holdings Ltd.
JHL Biotech, Inc.
Shrotriya Family Foundation
Wuhan Kindstar Co. Ltd.
IDG Capital Partners Co., Ltd.
CVie Therapeutics Co. Ltd.
American-Sino OB/GYN Hospital
Zenesis Ltd.
Intradigm Corp.
OMNI Pharmaceuticals (USA), Inc.
The UNLV Foundation
Smooth Prosper Ltd.
Cs Family Trust
GenScript Corp.
OriGene Technologies, Inc.
KPCB China Fund II LP
WUPIMA, Inc.
IDG Technology Venture Investment III LLC
Creditease Holdings Cayman Ltd.
Beijing Genetron Health Gene Technology Co. Ltd.
MZ Investment Holdings Ltd.
Allos Therapeutics, Inc.
IDG Technology Venture Investments LP
National Foundation for Cancer Research
IDG Technology Venture Investment IV LLC
© 2018 People , Fundamentals and Ownership